Gabriel Ling's most recent trade in Oncology Institute Inc (The) was a trade of 40,000 Common stock done . Disclosure was reported to the exchange on Nov. 22, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Oncology Institute Inc (The) | Gabriel Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 40,000 | 109,057 | - | 0 | Common stock | |
Oncology Institute Inc (The) | Gabriel Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 40,000 | 69,057 | - | 0 | Common stock | |
Oncology Institute Inc (The) | Gabriel Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 29,057 | 29,057 | - | 0 | Common Stock |